|
Optimizing Outcomes Through Personalized Relapsed/Refractory Multiple Myeloma Treatment: A Regional Workshop Series for the Entire Care Team
REGISTER TODAY
BECOME A MED-IQ MEMBER FOR FREE
Sign up today and access
award-winning medical education.
Learn more about your
member benefits.
Have questions?
Contact a Med-IQ Concierge Specialist. Call (toll-free)
866 858 7434 or e-mail
info@med-iq.com.
Med-IQ.
Inspiring Medical Education.
|
BALTIMORE, MD—July 1, 2014—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), invites community oncologists and other healthcare professionals who treat patients with multiple myeloma to attend the free CME/CE-certified workshop, Optimizing Outcomes Through Personalized Relapsed/Refractory Multiple Myeloma Treatment: A Regional Workshop Series for the Entire Care Team.
The introduction of immune-modulating drugs and proteasome inhibitors has recently transformed the treatment of relapsed and relapsed/refractory multiple myeloma. Although these agents and regimens based on these agents have offered new therapeutic opportunities, they are associated with significant side effects and risks. Many of these adverse events are preventable or manageable, and collaborative care among all members of the patient’s treatment team ensures the best outcomes. Additionally, clinicians can help improve care by providing patients with education to assist in self-management and possibly prevent complications.
“In each live workshop, we will explore factors that guide therapeutic decision making for patients with relapsed/refractory multiple myeloma,” said Joseph Mikhael, MD, MEd, FRCPC, FACP, Associate Dean, Mayo School of Graduate Medical Education at the Mayo Clinic in Scottsdale, AZ. “We will also review strategies for preventing, identifying, and managing adverse events that result from myeloma treatment. Participants in this workshop will be better equipped to manage patients who are in treatment for multiple myeloma and potentially improve quality of life for patients.”
This regional workshop series is being held in select cities across the country:
- Arlington, VA—July 19, 2014
- Atlanta, GA—July 26, 2014
- Boston, MA—August 16, 2014
- Chicago, IL—August 23, 2014 & September 27, 2014
- Detroit Area, MI—August 2, 2014
- Houston, TX—August 9, 2014
- New York, NY—July 26, 2014 & September 13, 2014
- Orange County, CA—September 13, 2014
- Philadelphia, PA—July 12, 2014
- Seattle, WA—September 27, 2014
Workshop Series Co-Chairs
 |
|
Joseph Mikhael, MD, MEd, FRCPC, FACP
Associate Dean, Mayo School of Graduate Medical Education
Deputy Director - Education, Mayo Clinic Cancer Center
Mayo Clinic
Scottsdale, AZ
|
 |
|
David S. Siegel, MD, PhD
Chief, Myeloma Division
John Theurer Cancer Center
Hackensack University Medical Center
Hackensack, NJ
|
The workshops will be held from 8:00 AM to 10:30 AM; breakfast will be served.
This activity is approved for AMA PRA Category 1 Credit™ and is supported by educational grants from Corporation, Millennium: The Takeda Oncology Company, and Onyx Pharmaceuticals.
Interested clinicians can register for free by calling (toll-free) 866 858 7434, e-mailing info@med-iq.com, or completing this brief online form. For more information on workshop locations and agenda, please visit www.Med-IQ.com/a789.
|
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management (CRM) to improve team performance and patient outcomes. These initiatives have achieved improvement in healthcare provider performance, quality of care, and patient outcomes. Med-IQ's work in performance and quality education and training has been published 27 times in peer-reviewed journals and has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
|
close
